about
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies f...
Read More
15.06
0.08
(0.53%)
96,697
XNAS Volume
High vol.+loss this week
XNAS 29 Jul, 2025 10:42 AM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
GH Research PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..